论文信息 - Interferon-alpha or homoharringtonine as salvage treatment for chronic myeloid leukemia patients who acquire the T315I BCR-ABL mutation. - 字舞流文

Interferon-alpha or homoharringtonine as salvage treatment for chronic myeloid leukemia patients who acquire the T315I BCR-ABL mutation.

D. Marin | J. Goldman | D. Milojković | J. Apperley | H. de Lavallade | J. Kaeda | J. Khorashad | H. P. Davis | D. Milojković | D. Milojkovic